The total number record retrieved from this search are 100. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_1149	Herpes simplex virus	NV1020	DNA	Herpesviridae	None	Yes	No	No	ATCC	Colon carcinoma cell line	SW480	2.0E+4 cells per well	NA	WST-1 assay	1 × 10⁶ pfu/ml	70% cell killing	No	No	NA	No response	NA	NA	NA	NA	17117895
OV_1150	Herpes simplex virus	NV1020	DNA	Herpesviridae	None	Yes	No	No	ATCC	Colon carcinoma cell line	SW620	1.0E+4 cells per well	NA	WST-1 assay	1 × 10⁶ pfu/ml	80% cell killing	No	No	NA	No response	NA	NA	NA	NA	17117895
OV_1151	Herpes simplex virus	NV1020	DNA	Herpesviridae	None	Yes	No	No	ATCC	Colon carcinoma cell line	LoVo	5.0E+3 cells per well	NA	WST-1 assay	1 × 10⁶ pfu/ml	60% cell killing	No	No	NA	No response	NA	NA	NA	NA	17117895
OV_1152	Herpes simplex virus	NV1020	DNA	Herpesviridae	None	Yes	No	No	ATCC	Colon carcinoma cell line	WiDr	1.5E+3 cells per well	NA	WST-1 assay	1 × 10⁶ pfu/ml	50% cell killing	No	No	NA	No response	NA	NA	NA	NA	17117895
OV_1153	Herpes simplex virus	NV1020	DNA	Herpesviridae	None	Yes	No	No	ATCC	Colon carcinoma cell line	LS174T	5.0E+3 cells per well	NA	WST-1 assay	1 × 10⁶ pfu/ml	70% cell killing	No	No	NA	No response	NA	NA	NA	NA	17117895
OV_1154	Herpes simplex virus	NV1020	DNA	Herpesviridae	None	Yes	No	No	ATCC	Colon carcinoma cell line	Caco-2	5.0E+3 cells per well	NA	WST-1 assay	1 × 10⁶ pfu/ml	80% cell killing	No	No	NA	No response	NA	NA	NA	NA	17117895
OV_1155	Herpes simplex virus	NV1020	DNA	Herpesviridae	None	Yes	No	No	ATCC	Colon carcinoma cell line	HT-29	2.5E+3 cells per well	NA	WST-1 assay	1 × 10⁶ pfu/ml	80% cell killing	No	No	NA	No response	NA	NA	NA	NA	17117895
OV_1156	Herpes simplex virus	NV1020	DNA	Herpesviridae	None	Yes	No	No	ATCC	Colon carcinoma cell line	HCT-116	1.25E+3 cells per well	NA	WST-1 assay	1 × 10⁶ pfu/ml	70% cell killing	No	No	NA	No response	NA	NA	NA	NA	17117895
OV_1157	Herpes simplex virus	NV1020	DNA	Herpesviridae	None	Yes	No	No	ATCC	Colon carcinoma cell line	CT-26	3.2E+2 cells per well	NA	WST-1 assay	1 × 10⁶ pfu/ml	90% cell killing	No	No	NA	No response	NA	NA	NA	NA	17117895
OV_1158	Herpes simplex virus	NV1020	DNA	Herpesviridae	None	No	Virus strain in combination with 5-FU	No	ATCC	Colon carcinoma cell line	HT-29	1.0E+3 cells per well	NA	WST-1 assay	1 × 10⁶ pfu/ml	Complete reduction in tumor,shows synergism with drug	No	No	NA	No response	NA	NA	NA	NA	17117895
OV_1159	Herpes simplex virus	NV1020	DNA	Herpesviridae	None	No	Virus strain in combination with SN-38	No	ATCC	Colon carcinoma cell line	HT-29	1.0E+3 cells per well	NA	WST-1 assay	1 × 10⁶ pfu/ml	Complete reduction in tumor,shows synergism with drug	No	No	NA	No response	NA	NA	NA	NA	17117895
OV_1160	Herpes simplex virus	NV1020	DNA	Herpesviridae	None	No	Virus strain in combination with 5-FU	No	ATCC	Colon carcinoma cell line	WiDr	80cells per well	NA	WST-1 assay	1 × 10⁴ pfu/ml	Synergistic effect	No	No	NA	No response	NA	NA	NA	NA	17117895
OV_1161	Herpes simplex virus	NV1020	DNA	Herpesviridae	None	No	5-FU in combination with virus	No	ATCC	Colon carcinoma cell line	WiDr	80cells per well	NA	WST-1 assay	1 × 10⁴ pfu/ml	Synergistic effect	No	No	NA	No response	NA	NA	NA	NA	17117895
OV_4242	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	ABC-1	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	100% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4243	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	ABC-1	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	80% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4244	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	ABC-1	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	60% cell viability after day 5	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4245	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	ABC-1	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	45% cell viability after day 7	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4246	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	National institute of biomedical innovation, Japan	Human nonsmall cell lung carcinoma cell line	NCI-H441	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	100% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4247	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	National institute of biomedical innovation, Japan	Human nonsmall cell lung carcinoma cell line	NCI-H441	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	80% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4248	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	National institute of biomedical innovation, Japan	Human nonsmall cell lung carcinoma cell line	NCI-H441	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	35% cell viability after day 5	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4249	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	National institute of biomedical innovation, Japan	Human nonsmall cell lung carcinoma cell line	NCI-H441	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	100% cell killing after day 7	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4250	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	ATCC	Human nonsmall cell lung carcinoma cell line	NCI-H2170	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	90% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4251	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	ATCC	Human nonsmall cell lung carcinoma cell line	NCI-H2170	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	38% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4252	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	ATCC	Human nonsmall cell lung carcinoma cell line	NCI-H2170	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	20% cell viability after day 5	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4253	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	ATCC	Human nonsmall cell lung carcinoma cell line	NCI-H2170	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	100% cell killing after day 7	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4254	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	ATCC	Human nonsmall cell lung carcinoma cell line	NCI-H358	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	100% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4255	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	ATCC	Human nonsmall cell lung carcinoma cell line	NCI-H358	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	55% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4256	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	ATCC	Human nonsmall cell lung carcinoma cell line	NCI-H358	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	30% cell viability after day 5	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4257	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	ATCC	Human nonsmall cell lung carcinoma cell line	NCI-H358	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	20% cell viability after day 7	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4258	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	Calu-3	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	100% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4259	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	Calu-3	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	80% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4260	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	Calu-3	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	42% cell viability after day 5	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4261	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	Calu-3	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	30% cell viability after day 7	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4262	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	ATCC	Human nonsmall cell lung carcinoma cell line	NCI-H1666	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	100% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4263	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	ATCC	Human nonsmall cell lung carcinoma cell line	NCI-H1666	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	60% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4264	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	ATCC	Human nonsmall cell lung carcinoma cell line	NCI-H1666	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	40% cell viability after day 5	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4265	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	ATCC	Human nonsmall cell lung carcinoma cell line	NCI-H1666	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	25% cell viability after day 7	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4266	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	PC-14	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	100% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4267	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	PC-14	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	100% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4268	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	PC-14	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	100% cell viability after day 5	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4269	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	PC-14	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	80% cell viability after day 7	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4270	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	A431	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	100% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4271	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	A431	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	100% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4272	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	A431	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	100% cell viability after day 5	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4273	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	NA	Human nonsmall cell lung carcinoma cell line	A431	5.0E+3 cells per well	NA	WST-1 assay	1 MOI	80% cell viability after day 7	No	No	NA	No response	NA	NA	NA	NA	26317644
OV_4633	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CF33	NA	NA	WST-1 assay	2 MOI	50% cell viability after 2 days	No	No	NA	No response	NA	NA	NA	NA	27093696
OV_4634	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CF33	NA	NA	WST-1 assay	2 MOI	30% cell viability after 4 days	No	No	NA	No response	NA	NA	NA	NA	27093696
OV_4635	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CF33	NA	NA	WST-1 assay	2 MOI	35% cell viability after 6 days	No	No	NA	No response	NA	NA	NA	NA	27093696
OV_4636	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CF33	NA	NA	WST-1 assay	2 MOI	30% cell viability after 8 days	No	No	NA	No response	NA	NA	NA	NA	27093696
OV_4637	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CTBm	NA	NA	WST-1 assay	2 MOI	100% cell viability after 2 days	No	No	NA	No response	NA	NA	NA	NA	27093696
OV_4638	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CTBm	NA	NA	WST-1 assay	2 MOI	80% cell viability after 4 days	No	No	NA	No response	NA	NA	NA	NA	27093696
OV_4639	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CTBm	NA	NA	WST-1 assay	2 MOI	60% cell viability after 6 days	No	No	NA	No response	NA	NA	NA	NA	27093696
OV_4640	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CTBm	NA	NA	WST-1 assay	2 MOI	50% cell viability after 8 days	No	No	NA	No response	NA	NA	NA	NA	27093696
OV_4641	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CHMm	NA	NA	WST-1 assay	2 MOI	100% cell viability after 2 days	No	No	NA	No response	NA	NA	NA	NA	27093696
OV_4642	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CHMm	NA	NA	WST-1 assay	2 MOI	40% cell viability after 4 days	No	No	NA	No response	NA	NA	NA	NA	27093696
OV_4643	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CHMm	NA	NA	WST-1 assay	2 MOI	40% cell viability after 4 days	No	No	NA	No response	NA	NA	NA	NA	27093696
OV_4644	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Univesity of Tokyo Japan	Canine mammary cancer	CHMm	NA	NA	WST-1 assay	2 MOI	40% cell viability after 4 days	No	No	NA	No response	NA	NA	NA	NA	27093696
OV_5160	Vesicular stomatitis virus	VSV-deltaGP	RNA	Rhabdoviridae	Virus lacking envelope protein G	Yes	No	No	University of vienna	Human ovarian cancer cell line	A2780	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	40% cell viable after 24 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5161	Vesicular stomatitis virus	VSV-MqdeltaG	RNA	Rhabdoviridae	Attenuated strain with 4 mutation in M protein and lacking G protein	Yes	No	No	University of vienna	Human ovarian cancer cell line	A2780	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	60% cell viable after 24 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5162	Vesicular stomatitis virus	VSV-deltaGP	RNA	Rhabdoviridae	Virus lacking envelope protein G	Yes	No	No	University of vienna	Human ovarian cancer cell line	A2780	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	100% cell killing after 48 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5163	Vesicular stomatitis virus	VSV-MqdeltaG	RNA	Rhabdoviridae	Attenuated strain with 4 mutation in M protein and lacking G protein	Yes	No	No	University of vienna	Human ovarian cancer cell line	A2780	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	100% cell killing after 48 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5164	Vesicular stomatitis virus	VSV-deltaGP	RNA	Rhabdoviridae	Virus lacking envelope protein G	Yes	No	No	University of vienna	Human ovarian cancer cell line	SKOV6	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	70% cell viable after 24 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5165	Vesicular stomatitis virus	VSV-MqdeltaG	RNA	Rhabdoviridae	Attenuated strain with 4 mutation in M protein and lacking G protein	Yes	No	No	University of vienna	Human ovarian cancer cell line	SKOV6	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	70% cell viable after 24 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5166	Vesicular stomatitis virus	VSV-deltaGP	RNA	Rhabdoviridae	Virus lacking envelope protein G	Yes	No	No	University of vienna	Human ovarian cancer cell line	SKOV6	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	30% cell viable after 48 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5167	Vesicular stomatitis virus	VSV-MqdeltaG	RNA	Rhabdoviridae	Attenuated strain with 4 mutation in M protein and lacking G protein	Yes	No	No	University of vienna	Human ovarian cancer cell line	SKOV6	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	20% cell viable after 48 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5168	Vesicular stomatitis virus	VSV-deltaGP	RNA	Rhabdoviridae	Virus lacking envelope protein G	Yes	No	No	University of vienna	Human ovarian cancer cell line	SKOV6	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	10% cell viable after 72 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5169	Vesicular stomatitis virus	VSV-MqdeltaG	RNA	Rhabdoviridae	Attenuated strain with 4 mutation in M protein and lacking G protein	Yes	No	No	University of vienna	Human ovarian cancer cell line	SKOV6	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	15% cell viable after 72 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5170	Vesicular stomatitis virus	VSV-deltaGP	RNA	Rhabdoviridae	Virus lacking envelope protein G	Yes	No	No	University of vienna	Human ovarian cancer cell line	HOC7	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	90% cell viable after 24 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5171	Vesicular stomatitis virus	VSV-MqdeltaG	RNA	Rhabdoviridae	Attenuated strain with 4 mutation in M protein and lacking G protein	Yes	No	No	University of vienna	Human ovarian cancer cell line	HOC7	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	90% cell viable after 24 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5172	Vesicular stomatitis virus	VSV-deltaGP	RNA	Rhabdoviridae	Virus lacking envelope protein G	Yes	No	No	University of vienna	Human ovarian cancer cell line	HOC7	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	60% cell viable after 48 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5173	Vesicular stomatitis virus	VSV-MqdeltaG	RNA	Rhabdoviridae	Attenuated strain with 4 mutation in M protein and lacking G protein	Yes	No	No	University of vienna	Human ovarian cancer cell line	HOC7	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	50% cell viable after 48 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5174	Vesicular stomatitis virus	VSV-deltaGP	RNA	Rhabdoviridae	Virus lacking envelope protein G	Yes	No	No	University of vienna	Human ovarian cancer cell line	HOC7	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	40% cell viable after 72 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5175	Vesicular stomatitis virus	VSV-MqdeltaG	RNA	Rhabdoviridae	Attenuated strain with 4 mutation in M protein and lacking G protein	Yes	No	No	University of vienna	Human ovarian cancer cell line	HOC7	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	40% cell viable after 72 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5176	Vesicular stomatitis virus	VSV-deltaGP	RNA	Rhabdoviridae	Virus lacking envelope protein G	Yes	No	No	ATCC	Human ovarian cancer cell line	OVCAR3	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	100% cell viable after 24 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5177	Vesicular stomatitis virus	VSV-MqdeltaG	RNA	Rhabdoviridae	Attenuated strain with 4 mutation in M protein and lacking G protein	Yes	No	No	ATCC	Human ovarian cancer cell line	OVCAR3	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	100% cell viable after 24 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5178	Vesicular stomatitis virus	VSV-deltaGP	RNA	Rhabdoviridae	Virus lacking envelope protein G	Yes	No	No	ATCC	Human ovarian cancer cell line	OVCAR3	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	100% cell viable after 48 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5179	Vesicular stomatitis virus	VSV-MqdeltaG	RNA	Rhabdoviridae	Attenuated strain with 4 mutation in M protein and lacking G protein	Yes	No	No	ATCC	Human ovarian cancer cell line	OVCAR3	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	20% cell viable after 48 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5180	Vesicular stomatitis virus	VSV-deltaGP	RNA	Rhabdoviridae	Virus lacking envelope protein G	Yes	No	No	ATCC	Human ovarian cancer cell line	OVCAR3	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	80% cell viable after 72 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5181	Vesicular stomatitis virus	VSV-MqdeltaG	RNA	Rhabdoviridae	Attenuated strain with 4 mutation in M protein and lacking G protein	Yes	No	No	ATCC	Human ovarian cancer cell line	OVCAR3	1.0E+5 cells per well	NA	WST-1 assay	1 MOI	10% cell viable after 72 hours	No	No	NA	No response	NA	NA	NA	NA	27738655
OV_5430	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	KLM1	NA	NA	WST-1 assay	1 MOI	60% cell viable after day 2	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5431	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	KLM1	NA	NA	WST-1 assay	1 MOI	10% cell viable after day 4	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5432	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	KLM1	NA	NA	WST-1 assay	1 MOI	100% cell killing after day 6	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5433	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	KLM1	NA	NA	WST-1 assay	1 MOI	100% cell killing after day 8	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5434	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	KLM1	NA	NA	WST-1 assay	1 MOI	100% cell killing after day 10	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5435	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	Capan-2	NA	NA	WST-1 assay	1 MOI	100% cell viable after day 2	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5436	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	Capan-2	NA	NA	WST-1 assay	1 MOI	80% cell viable after day 4	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5437	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	Capan-2	NA	NA	WST-1 assay	1 MOI	70% cell viable after day 6	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5438	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	Capan-2	NA	NA	WST-1 assay	1 MOI	50% cell viable after day 8	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5439	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	Capan-2	NA	NA	WST-1 assay	1 MOI	40% cell viable after day 10	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5440	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	PSN1	NA	NA	WST-1 assay	1 MOI	100% cell viable after day 2	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5441	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	PSN1	NA	NA	WST-1 assay	1 MOI	100% cell viable after day 4	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5442	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	PSN1	NA	NA	WST-1 assay	1 MOI	100% cell viable after day 6	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5443	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	PSN1	NA	NA	WST-1 assay	1 MOI	90% cell viable after day 8	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5444	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	PSN1	NA	NA	WST-1 assay	1 MOI	100% cell viable after day 10	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5445	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	PK1	NA	NA	WST-1 assay	1 MOI	100% cell viable after day 2	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5446	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	PK1	NA	NA	WST-1 assay	1 MOI	90% cell viable after day 4	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5447	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	PK1	NA	NA	WST-1 assay	1 MOI	100% cell viable after day 6	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5448	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	PK1	NA	NA	WST-1 assay	1 MOI	80% cell viable after day 8	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5449	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	PK1	NA	NA	WST-1 assay	1 MOI	60% cell viable after day 10	No	No	NA	No response	NA	NA	NA	NA	27561180
OV_5450	Measles virus	rMV-SLAMblind	RNA	Paramyxoviridae	R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle	Yes	No	No	Tohuku university Japan	Human pancreatic cancer cell line	PK9	NA	NA	WST-1 assay	1 MOI	90% cell viable after day 2	No	No	NA	No response	NA	NA	NA	NA	27561180